PMDA — authorised 1 August 2021
- Marketing authorisation holder: DAIICHI SANKYO COMPANY, LIMITED
- Status: approved
PMDA authorised Minnebro on 1 August 2021
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 1 August 2021; PMDA has authorised it.
DAIICHI SANKYO COMPANY, LIMITED holds the Japanese marketing authorisation.